Drug Type Immunoglobulin |
Synonyms- |
Target- |
Action modulators |
Mechanism Immunomodulators |
Therapeutic Areas |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date China (16 Jul 2020), |
Regulation- |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Autoimmune Diseases | China | 16 Jul 2020 | |
| Primary Immunodeficiency Diseases | China | 16 Jul 2020 | |
| Secondary immunodeficiencies | China | 16 Jul 2020 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Purpura, Thrombocytopenic, Idiopathic | Phase 3 | China | 07 Jan 2016 |






